+49 30 648 35 164 service@chameleon-pharma.com

FDA Approved the First Pharma Drug Made by 3D Printer

Recently, 3D printing technology once again proved that the reality is catching up with what once was only our imagination.

The new dissolvable pill “Spritam” has, with the help of 3D printing, been created by the private held company “Aprecia Pharmaceutical” and can be used for additional treatment of seizures by people suffering from epilepsy. The drug is the first of its kind to be approved by the American FDA.

The principle behind 3D printing is the multilayer printing and so called “raising” of a solid object via injection of different compounds. For pharmaceuticals, this means that medications can be layered and tightly packed into a single tablet, while simultaneously enabling the pill to instantly dissolve with just a sip of liquid. This new technique also allows a closer control of doses, as pills can be adjusted to individual needs.

Various industries have developed individual business concepts with making use of this new technology. Some branches of the healthcare industry are already using 3D printing. External organs like ears or noses or organ segments which have been damaged can be generated by the printers. Soon, 3D printers may enable the creation of whole organs, which would be a milestone in organ transplantation.

Featured image:  3D Printer by MKzero

Contact us

10 + 6 =

Related Posts

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s Maternal Healthcare Products: A Growing Opportunity for Consumer Health Companies towards 2040

Mexico’s large maternal care base continues to support demand for pregnancy supplements and women’s health products. According to INEGI, Mexico registered 1.67 million births in 2024, equal to 47.7 births per 1,000 women of fertile age. This creates regular demand for prenatal vitamins, folic acid, iron, calcium, DHA, and other Food Supplements supporting pregnancy, maternal wellbeing, and postpartum recovery.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis